Device Trial Radar · NCT01180140
Use of Seamguard to Prevent Leak and Bleeding in Gastrointestinal Surgery
Last checked: Nov 19, 2026Latest source record: Aug 11, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
113
Actual
Start
Mar 2006
Primary completion
Aug 2009
Study completion Jun 2010
Sponsor
- Lead sponsor
- Hospital Universitario de CanariasAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Unidad mixta de Investigación HUC-ULL; University of La Laguna
- First posted
- Aug 11, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determinate the utility of staple-line reinforcement on lineal gastrointestinal anastomoses. Hypothesis: Seamguard device will decrease the incidence of leak and bleeding in digestive lineal stapled anastomoses.
Conditions
- Leak on Lineal Stapled Anastomoses
- Bleeding on Lineal Stapled Anastomoses
Interventions
SeamguardDevice
GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement is specifically engineered to reduce the incidence of perioperative leaks and bleeding in a variety of open and minimally invasive surgeries. Then, after six months, it is completely absorbed eliminating the risk of a prolonged inflammatory response.
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.